[The importance of standardized periorbital steroid injections for thyroid-associated ophthalmopathy].
Zhonghua Yan Ke Za Zhi
; 58(9): 641-645, 2022 Sep 11.
Article
en Zh
| MEDLINE
| ID: mdl-36069084
ABSTRACT
Thyroid-associated ophthalmopathy (TAO) is now the most prevalent orbital disease in adults, with a complex pathophysiology and a wide range of clinical symptoms. In recent years, significant progress has been made in the research on the treatment of TAO. Periorbital steroid injections are considered a precise local treatment and can improve ocular symptoms with minor side effects. However, there is no standardized orbital injection protocol in China, resulting in increased complications. Therefore, it is essential to standardize periorbital steroid injections in treating TAO.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Oftalmopatía de Graves
Tipo de estudio:
Guideline
/
Risk_factors_studies
Límite:
Adult
/
Humans
País/Región como asunto:
Asia
Idioma:
Zh
Revista:
Zhonghua Yan Ke Za Zhi
Año:
2022
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
CHINA
/
CN
/
REPUBLIC OF CHINA